2021 annual financial data
Enliven Therapeutics 2021 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -24.76M USD and net income was -24.74M USD.
Operating cash flow was -19.13M USD.
Get free Enliven Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -24.76M USD
- Net income
- -24.74M USD
- Operating cash flow
- -19.13M USD